<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Bulletin of Semashko National Research Institute of Public Health</journal-id><journal-title-group><journal-title>Bulletin of Semashko National Research Institute of Public Health</journal-title></journal-title-group><issn publication-format="print">2415-8410</issn><issn publication-format="electronic">2415-8429</issn><publisher><publisher-name>FSSBI «N.A. Semashko National Research Institute of Public Health»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3206</article-id><article-id pub-id-type="doi">10.69541/NRIPH.2026.02.015</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Assessment of the economic effects of a complex of organizational measures for the implementation of innovative medical technologies using the example of a regional multidisciplinary medical organization</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gabrielyan</surname><given-names>Artur Rudolfovich</given-names></name><bio></bio><email>gabrielyanarthur@gmail.com</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mikhailov</surname><given-names>Ilya Aleksandrovich</given-names></name><bio></bio><email>mikhailov@rosmedex.ru</email><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff id="aff-1">State Budgetary Institution of Healthcare of the City of Moscow «City Clinical Hospital named after A. K. Yeramishantsev of the Moscow City Health Department», Moscow, Russian Federation</aff><aff id="aff-2">N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russian Federation</aff><aff id="aff-3">Federal State Budgetary Institution «Center for Expertise and Quality Control of Medical Care» of the Ministry of Health of the Russian Federation, Moscow, Russian Federation</aff><aff id="aff-4">Federal State Budgetary Educational Institution of Additional Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Health of the Russian Federation, Moscow, Russian Federation</aff><pub-date date-type="epub" iso-8601-date="2026-06-26" publication-format="electronic"><day>26</day><month>06</month><year>2026</year></pub-date><issue>2</issue><fpage>90</fpage><lpage>95</lpage><history><pub-date date-type="received" iso-8601-date="2026-06-27"><day>27</day><month>06</month><year>2026</year></pub-date></history><permissions><copyright-statement>Copyright © 2026,</copyright-statement><copyright-year>2026</copyright-year></permissions><abstract>Aim. To evaluate the economic effects of a set of organizational measures for the implementation of innovative medical technologies using the example of a regional multidisciplinary medical organization. Methods. The main (research) group (n=125) included patients who received medical care using innovative treatment methods. The introduction of these methods was preceded and accompanied by the implementation of a full range of developed organizational measures, including modules on staff retraining, optimization of clinical and diagnostic pathways, adaptation of internal regulations, and organization of post-procedural monitoring. The comparison group (n=68) included patients who received medical care using standard («routine») diagnostic and treatment methods in accordance with current clinical guidelines, but without the use of the studied BMI and associated organizational changes. The total sample size was 193 respondents. The weighted average base cost per bed-day was calculated at 453.50 rubles. This value was adopted as the base tariff for the conditional assessment of operating costs, excluding the cost of the treatment methods themselves, medications, and consumables, which made it possible to partially standardize the conditions for a comparative analysis of effectiveness. Results. In the group of patients who used innovative methods as part of the implemented set of organizational measures, the median length of hospitalization was 6.05 days (95% CI: 5.10 — 7.12 days). In the control group, who received treatment according to standard protocols, this indicator was significantly higher — 9.28 days (95% CI: 8.44 — 10.21 days). The statistical significance of the differences, confirmed using the Mann-Whitney U test, was p = 0.037. Thus, the implementation of innovative technologies in combination with systemic organizational changes made it possible to reduce the median length of hospitalization by 3.23 days. Taking into account the confidence intervals for the difference in the duration of treatment (from 2.35 to 3.48 days), the range of potential savings per case varies from 1,063.47 to 1,578.19 rubles. Taking into account confidence intervals, the total annual savings could range from RUB 35,639 million to RUB 52,888 million. Conclusion. Thus, the economic efficiency of implementing innovative medical technologies is indirect and largely determined by the quality of preceding and accompanying organizational decisions. A comprehensive approach combining technological modernization with the reengineering of clinical and management processes enables the clinical benefits of innovation to be transformed into measurable economic benefits for the compulsory health insurance system, contributing to the increased financial sustainability of healthcare organizations in resource-constrained environments.</abstract><kwd-group xml:lang="en"><kwd>economic efficiency, social efficiency, hospitalization time, innovative technologies, healthcare management, medical organization, implementation of innovative medical technologies, clinical testing</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>экономическая эффективность, социальная эффективность, сроки госпитализации, инновационные технологии, управление здравоохранением, медицинская организация, внедрение инновационных медицинских технологий, клиническая апробация</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nxele S. R., Moetlhoa B., Kgarosi K., Mashamba-Thompson T. A scoping review protocol on integration of mobile-linked POC diagnostics in community-based healthcare: User experience. PLoS One. 2023;18:e0276827. DOI: 10.1371/journal.pone.0276827</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kaitz J., DeLaughter K., Deeney C., Cutrona S. L., Hogan T. P., Gifford A. L., et al. Leveraging Organizational Conditions for Innovation: A Typology of Facility Engagement in the Veterans Health Administration Shark Tank-Style Competition. Perm. J. 2023;27:43—50. DOI: 10.7812/TPP/22.154</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lewinski A. A., Sullivan C., Allen K. D., Crowley M. J., Gierisch J. M., Goldstein K. M., et al. Accelerating Implementation of Virtual Care in an Integrated Health Care System: Future Research and Operations Priorities. J. Gen. Intern. Med. 2021;36:2434—42. DOI: 10.1007/s11606-020-06517-3</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wali S., Superina S., Mashford-Pringle A., Ross H., Cafazzo J. A. What do you mean by engagement? — evaluating the use of community engagement in the design and implementation of chronic disease-based interventions for Indigenous populations — scoping review. Int. J. Equity Health. 2021;20:8. DOI: 10.1186/s12939-020-01346-6</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gardner J., Herron D., McNally N., Williams B. Advancing the digital and computational capabilities of healthcare providers: A qualitative study of a hospital organization in the NHS. Digit. Heal. 2023;9:20552076231186510. DOI: 10.1177/20552076231186513</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Baral R., Levin A., Odero C., Pecenka C., Tabu C., Mwendo E., et al. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries. PLoS One. 2021;16:e0244995. DOI: 10.1371/journal.pone.0244995</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Oh A. Y., Emmons K. M., Brownson R. C., Glasgow R. E., Foley K. L., Lewis C. C., et al. Speeding implementation in cancer: The National Cancer Institute&amp;apos;s Implementation Science Centers in Cancer Control. J. Natl. Cancer Inst. 2023;115:131—8. DOI: 10.1093/jnci/djac198</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Matthew A. G., Incze T., Stragapede E., Guirguis S., Neil-Sztrampko S. E., Elterman D. S. Implementation of a sexual health clinic in an oncology setting: patient and provider perspectives. BMC Health Serv. Res. 2025;25:123. DOI: 10.1186/s12913-024-12092-8</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Габриелян А. Р. Новый тип структурного подразделения многопрофильной медицинской организации — центр по внедрению инновационных технологий медицинской организации. Бюллетень Национального научно-исследовательского института общественного здоровья имени Н. А. Семашко. 2025;(3):92—95. DOI: 10.69541/NRIPH.2025.03.014</mixed-citation></ref></ref-list></back></article>
